当前位置: 首页 > 期刊 > 《中国现代医生》 > 2021年第18期
编号:669810
PI3K-Akt-mTOR通路在慢阻肺发病机制中的研究进展
http://www.100md.com 2021年11月30日 中国现代医生 2021年第18期
     唐艺玲 张培蓓 叶贤伟

    [关键词] PI3K-Akt-mTOR;慢性阻塞性肺疾病(慢阻肺);自噬;基因治疗

    [中图分类号] R856.3? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-9701(2021)18-0178-06

    Research progress of PI3K-Akt-mTOR pathway in the pathogenesis of chronic obstructive pulmonary disease

    TANG Yiling1? ?ZHANG Peibei2,3? ?YE Xianwei1, 3

    1.Zunyi Medical University,Zunyi 563000,China;2.Department of Respiratory and Critical Care Medicine,Guizhou Provincial People's Hospital, Guiyang 550000, China; 3.Key Laboratory of Pulmonary Immune Diseases, National Health Commission, Guiyang? ?550000, China

    [Abstract] Chronic obstructive pulmonary disease (abbreviated as COPD), which is an inflammatory disease of the airway in the respiratory mechanism of the human body, has a certain commonness, and its morbidity and fatality rate are both high. It is an important global public health issue. Through related investigations, it is found that the phosphatidylinositol 3-kinase/protein kinase B/target of rapamycin (P13K-Akt-mTOR) signaling pathway is involved in many aspects of the cell, such as proliferation, apoptosis, and autophagy ......

您现在查看是摘要页,全文长 21213 字符